Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objectives of this registry are to assess the use of the thrombin-specific anticoagulant bivalirudin during percutaneous coronary intervention (PCI) in a real life setting. In particular, data will be collected to analyze experiences of bivalirudin use in respect to the following objectives;
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bivalirudin | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| To assess the use of the thrombin-specific anticoagulant bivalirudin during percutaneous coronary intervention (PCI) in a real life setting. In particular, data will be collected to analyze experiences of bivalirudin use in respect to the following; | ||
| •examine the aspects of safety and effectiveness of bivalirudin | ||
| •gain experience regarding the characteristics of patients in bivalirudin treatment | ||
| •evaluate the handling of bivalirudin and its practicality. |
Not provided
Not provided
Inclusion Criteria:
> 18 years, undergoing planned or urgent PCI with the intention to use bivalirudin as anticoagulant, written informed concent to entry of data information registry.
Exclusion Criteria:
None
Not provided
Not provided
Primary Care Clinic
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nycomed Clinical Trial Operations | Headquaters | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nycomed | Roskilde | 4000 | Denmark |
Not provided
| ID | Term |
|---|---|
| C074619 | bivalirudin |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided